FDA Approved: YUSIMRY — Supplemental Application (Coherus BioSciences Inc)

View source ↗

Summary

FDA approved a supplemental Biologics License Application for YUSIMRY (adalimumab-aqvh) by Coherus BioSciences, authorizing the biosimilar product to be markete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Hidradenitis Suppurativa
• Noninfectious Uveitis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• YUSIMRY (ADALIMUMAB-AQVH)

Snippet

SUPPL AP for YUSIMRY (ADALIMUMAB-AQVH)